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Summary
Dent et al
1 reported a study entitled “Accuracy of the diag-
nosis of GORD by questionnaire, physicians and a trial of proton 
pump inhibitor treatment: The Diamond Study” in the June 2010 
issue of Gut.
Patients with symptoms considered by their family practi-
tioner to be of upper gastrointestinal origin were enrolled from 6 
countries (n = 308). The Reflux Disease Questionnaire (RDQ) 
was completed and a symptom-based diagnosis was made by the 
family practitioner.
2 Placebo esomeprazole was started after the 
diagnosis. Gastroenterologists made a symptom-based diagnosis 
and then performed endoscopy and wireless 48 hour esophageal 
pH recordings with monitoring of associated symptoms; the find-
ings were used to determine the reference standard for the pres-
ence or absence of gastroesophageal reflux disease (GERD). Sy-
mptoms were recorded during treatment with 40 mg of esome-
prazole for 2 weeks. The main outcome measure was RDQ scor-
ing for the presence of GERD compared to the symptom-based 
diagnosis by family physicians and gastroenterologists.
GERD was present in 203/308 (66%) of the patients. Only 
49% of the patients with GERD reported either heartburn or re-
gurgitation as their most troublesome symptom. The sensitivity 
and specificity of the symptom-based diagnosis of GERD, were 
62% and 67% for the RDQ, 63% and 63% for the family practi-
tioners, 67% and 70% for the gastroenterologists and 54% and 
65% for the 2-week trial of proton pump inhibitor (PPI) treat-
ment. 
The symptom-based diagnosis of GERD by the RDQ, fam-
ily practitioners and gastroenterologists had moderate and similar 
accuracy. Symptom response to a 2-week course of 40 mg of 
esopmeprazole did not increase the diagnostic accuracy.
Comment
Although heartburn and acid regurgitation are considered to 
be distinctive symptoms of GERD and current guidelines rec-
ommend making a clinical diagnosis of GERD based on these 
symptoms,
3,4 research on the spectrum of symptoms associated 
with GERD and the accuracy of a symptom-based diagnosis has 
been limited. This study provides rigorous validation of symp-Accuracy of the Diagnosis of GERD
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tom-based diagnostic assessment by a self-report questionnaire 
and physician’s skills acquired by experience in clinical practice. 
The authors also tried to evaluate whether a 2-week trial of PPI 
treatment would enhance the accuracy of the symptom-based di-
agnosis of GERD. 
This study provides novel insights into the accuracy of vari-
ous diagnostic modalities for GERD. The authors reported that 
the sensitivity and specificity, for the diagnosis of GERD was 
49% and 74%, respectively, for the symptom-based diagnosis 
with heartburn or regurgitation as the most troublesome present-
ing symptom, and 71% and 44%, respectively, for a 2-week trial 
of standard-dose esomeprazole treatment in the subgroup of pa-
tients that reported typical GERD symptoms. Although the PPI 
test is accepted as a useful and sensitive tool that allows physicians 
to make a rapid and fairly accurate diagnosis of GERD,
5 there 
has been conflicting results regarding its diagnostic accuracy in 
patients with classic GERD-related symptoms.
6 Current guide-
lines recommend an empirical trial of a PPI to diagnose GERD 
in patients with typical GERD symptoms.
3,4 However, there has 
been no consensus on the  guidelines for the accurate dose and 
duration of PPI treatment or the optimal cutoff value for the 
symptom score defining a positive response. In this study, a 
2-week trial of PPI treatment showed just moderate accuracy for 
diagnosing GERD; therefore, the authors recommended re-
ducing apparently unwarranted confidence in the value of PPI 
test. In addition, endoscopy and esophageal pH monitoring with 
symptom-association probability showed limited utility for the di-
agnosis of GERD due to the moderate sensitivity (57% and 66%, 
respectively). The authors emphasized that although a symp-
tom-based diagnosis by questionnaire and physicians provided 
less than ideal diagnostic accuracy, it was an inexpensive, imme-
diately available option, especially in the primary care setting, 
when compared to the limited efficacy of other modalities for the 
diagnosis of GERD.
In addition, the authors reported that only 49% of patients re-
ported heartburn or regurgitation as their most troublesome 
symptom and 21.2% of patients reported dyspepsia, defined as 
pain or discomfort in the center of the upper abdomen, as the sec-
ond most troublesome symptom. In patients without GERD, 
heartburn and dyspepsia were observed almost as frequently. 
Based on these findings, an overlap in symptoms between pa-
tients with GERD and patients with dyspepsia without GERD 
was evident; therefore, a substantial proportion of patients present-
ing with dyspepsia might have GERD, even though the symp-
tom-based diagnosis might not identify heartburn or reflux symp-
toms. For example, almost 20% of patients with functional dys-
pepsia and a negative heartburn questionnaire had pathological 
esophageal acid exposure,
7 and endoscopic reflux esophagitis was 
found in 18.8% of dyspeptic patients without heartburn or re-
gurgitation.
8 Thus, there may be a wide spectrum of presenting 
symptoms in patients with or without GERD in primary care, 
and this can be challenging for the symptom-based diagnosis. 
Taken together, to improve the accuracy of the diagnosis, addi-
tional studies are needed with different symptom assessment de-
signs using questionnaire methods. 
There are several points that should be considered. First, al-
though this study has important strengths associated with the 3 
independently performed symptom-based diagnostic assess-
ments, 39.3% of enrolled patients dropped out during the study; 
in addition, this study was performed only in developed coun-
tries, and may not be generalized to the populations with a high 
prevalence of Helicobacter pylori infection.
In conclusion, this study suggests that there is no single per-
fect test for GERD. Currently, the best approach to the diagnosis 
of GERD relies on multiple steps, with the symptom-based 
approach.
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